Furthermore, silencing of SOCS1 in breast cancer cells reestablishes the oncogenic effects of miR-155, while restoring SOCS1 expression promotes the pro-tumorigenesis function of miR-155, which indicates that miR-155 negatively regulates SOCS1. This evidence concerns the gene SOCS1 and breast cancer.